N-Acetyltransferase 15 (NAT15) (N-Term) Peptide
-
- Target See all NAT15 products
- NAT15 (N-Acetyltransferase 15 (NAT15))
- Protein Region
- N-Term
- Origin
- Human, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- IVGMIVAEIK NRTKIHKEDG DILASSFSVD TQVAYILSLG VVKEFRKHGI
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Naa60 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NAT15 (N-Acetyltransferase 15 (NAT15))
- Background
-
Naa60 displays alpha (N-terminal) acetyltransferase activity towards a range of N-terminal sequences including those starting with Met-Lys, Met-Val, Met-Ala and Met-Met. Required for normal chromosomal segregation during anaphase.
Alias Symbols: MGC124897, RGD1308915
Protein Size: 242 - Molecular Weight
- 26 kDa
- Gene ID
- 363545
- NCBI Accession
- NM_001014226, NP_001014248
- UniProt
- Q3MHC1
-